Respiratory Biology Recommendations

To view Article Recommendations, you must have an active subscription.

If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.

If you think you should be able to access this content, please contact us.

New to F1000? See this week’s top article below for a free preview of a Recommendation.

Take the tour.

The Respiratory Biology Faculty has been created by grouping relevant Sections from other F1000 Faculties, it therefore does not have separate Heads of Faculty, Section Heads or Faculty Members.

LATEST RECOMMENDATION

The Imatinib in Pulmonary Arterial Hypertension, a Randomized, Efficacy Study (IMPRES) trial is a large, well-designed clinical study to determine whether addition of imatinib mesylate, a tyrosine kinase inhibitor that targets platelet-derived growth factor (PDGF...

Vinicio de Jesus Perez, Stanford University Medical Center, USA. F1000 Respiratory Disorders

Score:

Past 7 Days

New Recommendations

1,477 total

New Articles Recommended

1,084 total

Past 30 Days

11

Articles Classified As Controversial

156 total
20

Articles Classified As Novel Drug Target

329 total
4

Articles Classified As Confirmation

233 total
4

Articles Classified As Technical Advance

184 total
31

Articles Classified As New Finding

1,136 total
16

Articles Classified As Interesting Hypothesis

336 total
4

Articles Classified As Good for Teaching

25 total

INDIVIDUAL SUBSCRIPTIONS

Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.

Start your personal subscription today.

Subscribe for $9.95/month

Take the tour.